Literature DB >> 9511084

Nitric oxide in sepsis and endotoxaemia.

J R Parratt1.   

Abstract

Nitric oxide (NO) is one of many vasoactive substances released, from a variety of cells, under conditions of endotoxaemia and sepsis. Under physiological conditions it is produced by two constitutive calcium-dependent enzymes (nitric oxide synthase; NOS) in neurones (nNOS) and endothelial cells (eNOS) and has functions ranging from neurotransmission and vasodilatation to inhibition of platelet adhesion and aggregation. Following bacterial infection, especially with Gram-negative organisms, its formation from L-arginine is enhanced due to the cytokine-mediated induction of a NOS enzyme (iNOS) in cells (e.g. cardiac myocytes, vascular smooth muscle) that do not normally have the ability to synthesize NO. The result of this excessive NO production is enhanced bacterial lysis by activated macrophages, vasoplegia and myocardial depression. These cardiovascular effects can be alleviated by inhibitors of the L-arginine NO pathway, which results in elevated perfusion pressure, restored responsiveness to sympathetic nerve stimulation and to exogenous catecholamines, and to enhanced (endothelin-dependent) myocardial contractility. In patients in shock this approach also leads to detrimental effects (increased systemic vascular resistance, elevated pulmonary artery pressure, reduced cardiac output and oxygen delivery, increased platelet accumulation) and survival is not improved. Because some of these detrimental effects are due to inhibition of eNOS, attempts have been made to examine the effects of substances with a higher selectivity for the induced form of the enzyme. In experimental animals, one of these (L-canavanine) protects endothelial cells from damage, increases survival time and restores vascular responsiveness without increasing blood pressure or peripheral vascular resistance. However, whether even this approach will be of benefit to patients with sepsis remains in doubt since studies in iNOS knock-out mice do not support the concept that eliminating this particular source of NO improves ultimate survival.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9511084     DOI: 10.1093/jac/41.suppl_1.31

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  19 in total

1.  Decisions, directions, defects and fellow disciples (A rückblick of 50 years of basic medical research).

Authors:  James Roy Parratt
Journal:  Exp Clin Cardiol       Date:  2010

2.  The role of endothelium and endogenous vasoactive substances in sepsis.

Authors:  G Kotsovolis; K Kallaras
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

3.  Reinforcement therapy using nitric oxide synthase inhibitors against endotoxin shock in dogs.

Authors:  Hiroyasu Suga; Takao Nakagawa; Yukihiro Soga; Yoshizumi Deguchi; Tadashi Suzuki; Norio Miyoshi; Yoshiaki Imamura; Masaru Fukuda
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Inotropic response to endothelin-1, isoprenaline and calcium in cardiomyocytes isolated from endotoxin treated rats: effects of ethyl-isothiourea and dexamethasone.

Authors:  J P Spiers; E J Kelso; J D Allen; B Silke; B J McDermott
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  S-nitrosylation of mixed lineage kinase 3 contributes to its activation after cerebral ischemia.

Authors:  Shu-Qun Hu; Jun-Song Ye; Yan-Yan Zong; Chang-Cheng Sun; Dong-Hai Liu; Yong-Ping Wu; Tao Song; Guang-Yi Zhang
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

6.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

Review 7.  Demystified. Nitric oxide.

Authors:  K Stuart-Smith
Journal:  Mol Pathol       Date:  2002-12

8.  Thaliporphine ameliorates cardiac depression in endotoxemic rats through attenuating TLR4 signaling in the downstream of TAK-1 phosphorylation and NF-κB signaling.

Authors:  Wen-Pin Chen; Hsiao-Jung Tzeng; Hui-Chun Ku; Yi-Jin Ho; Shoei-Sheng Lee; Ming-Jai Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-09-17       Impact factor: 3.000

9.  Insulin signaling in skeletal muscle and liver of neonatal pigs during endotoxemia.

Authors:  Renán A Orellana; Agus Suryawan; Scot R Kimball; Guoyao Wu; Hanh V Nguyen; Leonard S Jefferson; Teresa A Davis
Journal:  Pediatr Res       Date:  2008-11       Impact factor: 3.756

10.  Netropsin improves survival from endotoxaemia by disrupting HMGA1 binding to the NOS2 promoter.

Authors:  Marianne A Grant; Rebecca M Baron; Alvaro A Macias; Matthew D Layne; Mark A Perrella; Alan C Rigby
Journal:  Biochem J       Date:  2009-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.